Treatment-free remission as a new goal in the management of chronic myeloid leukemia: Clinical and biological aspects
{{output}}
The therapeutic armamentarium of chronic myeloid leukemia (CML) has dramatically improved after small molecule tyrosine kinase inhibitors (TKIs) targeting BCR::ABL1 became available, with a life expectancy now close to that of the general population. Although ... ...
